+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiovascular Implants Market by Product Type, Application, End-User, Approach, Technology, Material - Global Forecast to 2030- Product Image
Cardiovascular Implants Market by Product Type, Application, End-User, Approach, Technology, Material - Global Forecast to 2030- Product Image
Sale

Cardiovascular Implants Market by Product Type, Application, End-User, Approach, Technology, Material - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010720
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cardiovascular implants market is experiencing significant transformation as demographic changes, healthcare demands, and rapid advances in device technologies converge. Senior leaders must navigate complex innovation cycles, evolving regulations, and new cost structures. This analysis delivers actionable insights tailored for informed portfolio and investment decisions.

Market Snapshot: Cardiovascular Implants Market Growth and Trajectory

Driven by global surges in chronic heart conditions and steady advancements in medical technology, the cardiovascular implants market grew from USD 35.30 billion in 2024 to USD 37.60 billion in 2025. The sector is projected to continue its momentum at a 6.23% CAGR, with revenues anticipated to reach USD 50.75 billion by 2030. Heightened need for heart repair solutions, coupled with regulatory and investment shifts, underscores robust expansion across established and emerging markets.

Scope & Segmentation

  • Product Types: Heart valves (mechanical, tissue such as bovine, equine, and porcine), implantable cardioverter defibrillators (dual and single chamber), occluders (atrial septal defect, patent foramen ovale), pacemakers (biventricular, dual, single chamber), stents (bare metal, drug eluting including paclitaxel and sirolimus), vascular grafts (biological allograft, autograft, xenograft, synthetic).
  • Applications: Coronary and peripheral (including carotid, iliac, renal vascular cases).
  • Approaches: Minimally invasive and open surgical methodologies.
  • End Users: Ambulatory surgical centers, hospitals, specialty clinics.
  • Technologies: Bare metal, bioabsorbable, and drug eluting platforms.
  • Materials: Biological tissue, metal, polymer; with movement toward hybrid composite innovations.
  • Regions Covered: Americas (United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; plus Canada, Mexico, Brazil, Argentina). Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland). Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Notable Organizations: Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, Johnson & Johnson, BIOTRONIK SE & Co. KG, Terumo Corporation, MicroPort Scientific Corporation, LivaNova PLC, Lepu Medical Technology Co., Ltd.

Key Takeaways for Senior Decision-Makers

  • Emerging materials science and digital health integration are accelerating product innovation, improving device life cycles, and enhancing patient monitoring capabilities.
  • Regulatory transitions are influencing device approval timelines, making regulatory agility and relationship management a critical success factor.
  • Collaborative models—linking manufacturers, research centers, and clinical specialists—are shortening design cycles and supporting faster translation of new technologies into practice.
  • Personalized implant strategies are advancing, combining biocompatible technologies and real-time data monitoring for tailored patient care.
  • Regional differences in adoption and infrastructure remain pronounced, requiring nuanced go-to-market approaches for optimal coverage and growth.
  • Strategic partnerships and targeted R&D investments are strengthening footholds in high-growth segments and regions.

Tariff Impact: Navigating the New Cost Structure

Recent United States tariffs on cardiovascular implant raw materials and devices are raising procurement costs, pressuring manufacturers to re-examine sourcing, pricing, and supply chain logistics. Many device developers are localizing manufacturing and forming public-private partnerships to mitigate import levies, though these transitions require significant capital and introduce interim production challenges. Healthcare providers are simultaneously experiencing tighter margins as reimbursement rarely keeps pace with rising device costs. Strategic sourcing diversification and operations optimization are proving essential for maintaining competitiveness in the shifting tariff environment.

Methodology & Data Sources

This cardiovascular implants market analysis is grounded in both comprehensive secondary research and direct interviews with clinicians, procurement leaders, and executives. The methodology included reviews of regulatory and industry databases, validation by expert panels, and the integration of proprietary device usage and patent data. All insights are peer-reviewed, ensuring objectivity and precision for executive decision support.

Why This Report Matters: Executive Value

  • Provides a holistic market view to inform strategic portfolio and geographic expansion planning.
  • Delivers actionable insights on product, technology, and supply chain developments, helping leaders identify and prioritize high-growth opportunities.
  • Supports data-driven decisions in response to regulatory, clinical, and economic market shifts.

Conclusion

The cardiovascular implants market is advancing through technological integration, regulatory evolution, and shifting global economics. Leaders who leverage these insights can position their organizations to adapt, innovate, and drive sustained market advantage in a dynamic landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cardiovascular Implants Market, by Product Type
8.1. Introduction
8.2. Heart Valves
8.2.1. Mechanical
8.2.2. Tissue
8.2.2.1. Bovine
8.2.2.2. Equine
8.2.2.3. Porcine
8.3. Implantable Cardioverter Defibrillators
8.3.1. Dual Chamber
8.3.2. Single Chamber
8.4. Occluders
8.4.1. Atrial Septal Defect
8.4.2. Patent Foramen Ovale
8.5. Pacemakers
8.5.1. Biventricular
8.5.2. Dual Chamber
8.5.3. Single Chamber
8.6. Stents
8.6.1. Bare Metal
8.6.2. Drug Eluting
8.6.2.1. Paclitaxel
8.6.2.2. Sirolimus
8.7. Vascular Grafts
8.7.1. Biological
8.7.1.1. Allograft
8.7.1.2. Autograft
8.7.1.3. Xenograft
8.7.2. Synthetic
9. Cardiovascular Implants Market, by Application
9.1. Introduction
9.2. Coronary
9.3. Peripheral
9.3.1. Carotid
9.3.2. Iliac
9.3.3. Renal
10. Cardiovascular Implants Market, by End-User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Cardiovascular Implants Market, by Approach
11.1. Introduction
11.2. Minimally Invasive
11.3. Open Surgical
12. Cardiovascular Implants Market, by Technology
12.1. Introduction
12.2. Bare Metal
12.3. Bioabsorbable
12.4. Drug Eluting
13. Cardiovascular Implants Market, by Material
13.1. Introduction
13.2. Biological Tissue
13.3. Metal
13.4. Polymer
14. Americas Cardiovascular Implants Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Cardiovascular Implants Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Cardiovascular Implants Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Medtronic plc
17.3.2. Abbott Laboratories
17.3.3. Boston Scientific Corporation
17.3.4. Edwards Lifesciences Corporation
17.3.5. Johnson & Johnson
17.3.6. BIOTRONIK SE & Co. KG
17.3.7. Terumo Corporation
17.3.8. MicroPort Scientific Corporation
17.3.9. LivaNova PLC
17.3.10. Lepu Medical Technology Co., Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CARDIOVASCULAR IMPLANTS MARKET MULTI-CURRENCY
FIGURE 2. CARDIOVASCULAR IMPLANTS MARKET MULTI-LANGUAGE
FIGURE 3. CARDIOVASCULAR IMPLANTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. CARDIOVASCULAR IMPLANTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. CARDIOVASCULAR IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CARDIOVASCULAR IMPLANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY EQUINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DUAL CHAMBER, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY ATRIAL SEPTAL DEFECT, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PATENT FORAMEN OVALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIVENTRICULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DUAL CHAMBER, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BARE METAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACLITAXEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SIROLIMUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY ALLOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY AUTOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CORONARY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CAROTID, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY ILIAC, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY RENAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OPEN SURGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BARE METAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOABSORBABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY METAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY POLYMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 99. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 101. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 102. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
TABLE 103. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 104. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
TABLE 105. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 106. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 107. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 108. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
TABLE 109. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 111. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 113. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 115. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 117. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 118. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
TABLE 119. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 120. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
TABLE 121. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 122. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 123. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 124. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
TABLE 125. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 127. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 129. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 130. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 196. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 198. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 199. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
TABLE 200. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 201. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
TABLE 202. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 203. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 204. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 205. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
TABLE 206. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 208. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 210. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 211. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 212. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 213. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 214. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 215. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
TABLE 216. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 217. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
TABLE 218. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 219. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 220. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 221. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
TABLE 222. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 224. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 226. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 240. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 241. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 242. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 244. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 246. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 247. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
TABLE 248. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 249. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
TABLE 250. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 251. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 252. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 253. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
TABLE 254. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 256. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 257. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 258. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 259. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 260. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 262. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 263. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
TABLE 264. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 265. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
TABLE 266. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 267. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 268. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 269. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
TABLE 270. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 272. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 273. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 274. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 275. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 292. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 294. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
TABLE 296. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
TABLE 298. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 300. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
TABLE 302. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 304. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 306. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 308. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 310. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
TABLE 312. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
TABLE 314. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY DRUG ELUTING, 2018-2030 (USD MILLION)
TABLE 316. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
TABLE 318. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL, 2018-2030 (USD MILLION)
TABLE 320. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 322. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 324. DENMARK CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 325. DENMARK CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, 2018-2030 (USD MILLION)
TABLE 326. DENMARK CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
TABLE 327. DENMARK CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
TABLE 328. DENMARK CARDIOVASCULAR IMPLANTS MARKET SIZE, BY OCCLUDERS, 2018-2030 (USD MILLION)
TABLE 329. DENMAR

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cardiovascular Implants market report include:
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Johnson & Johnson
  • BIOTRONIK SE & Co. KG
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • LivaNova PLC
  • Lepu Medical Technology Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages184
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 37.6 Billion
Forecasted Market Value ( USD ) by 2030 $ 50.75 Billion
Compound Annual Growth Rate6.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cardiovascular Implants Market Report 2025 - Product Image

Cardiovascular Implants Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Biological Implants Market by Orthopedic Implants, Cardiovascular Implants, Dental Implants, Spinal Implants, Neurological Implants, Ocular Implants - Global Forecast to 2030 - Product Image

Biological Implants Market by Orthopedic Implants, Cardiovascular Implants, Dental Implants, Spinal Implants, Neurological Implants, Ocular Implants - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Cardiovascular Implants Market Report by Product Type, Material, Procedure Type, Indication, and Region 2025-2033 - Product Image

Cardiovascular Implants Market Report by Product Type, Material, Procedure Type, Indication, and Region 2025-2033

  • Report
  • 143 Pages
  • Global
From
Cardiovascular Implants - Global Strategic Business Report - Product Image

Cardiovascular Implants - Global Strategic Business Report

  • Report
  • 188 Pages
  • Global
From
Cardiovascular Devices Market by Device Type, Operation Type, Access Type, Application, End User - Global Forecast to 2030 - Product Image

Cardiovascular Devices Market by Device Type, Operation Type, Access Type, Application, End User - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From

About the Cardiovascular Implant Market

The Cardiovascular Implant market is a subset of the Cardiovascular Devices market, which includes a wide range of products used to diagnose, treat, and monitor cardiovascular diseases. Cardiovascular Implants are medical devices that are surgically implanted into the body to treat cardiovascular diseases. These devices include pacemakers, implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs). They are designed to regulate the heart rate, detect arrhythmias, and provide mechanical support to the heart. Cardiovascular Implants are used to treat a variety of cardiovascular diseases, including arrhythmias, heart failure, and coronary artery disease. They are also used to improve the quality of life of patients with cardiovascular diseases. Some of the major companies in the Cardiovascular Implant market include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and Sorin Group. These companies are involved in the development, manufacturing, and marketing of cardiovascular implants. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.